Q2 FY26: Revenue up 34% YoY, DyStar sale deadline extended to Dec 1

Emphasis Of MatterResults RestatedRevenue Growth 20pctEbitda Margin CompressionPat NegativeNegative Operating CashflowResults View source PDF Explain this filing

KIRIINDUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.7%Reaction day

₹529.75

prior close

₹535.60

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+1.3% vs market

Dyes And Pigments peers, median of 8sector-0.6%+2.3% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250 and 2.3 pts more than its Dyes And Pigments peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.9

10m

+0.2

15m

+0.8

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.7+0.4+1.3-0.6+2.3

Next day

+0.9+0.0+0.9-2.2+3.1

-0.5-0.2-0.3-2.2+1.7

-1.3+0.7-2.0-1.4+0.1

-1.0+0.6-1.5-3.2+2.3

-0.5+0.5-1.0-2.4+1.9

+0.6+0.3+0.3-3.6+4.2

15d

+10.9-1.5+12.4-5.7+16.6

+9.9-6.6+16.4-10.7+20.6

+3.1-3.2+6.2-7.9+11.0

-2.2-5.2+3.0-12.0+9.8

UpDownMarket · Nifty Microcap 250Sector · Dyes And Pigments peers, median of 8Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q2/H1 FY26 unaudited results. Standalone revenue at Rs 194.62 cr, up 34% YoY, but loss after tax of Rs 21.12 cr. Consolidated revenue Rs 213.44 cr, up 23% YoY, with negative EBITDA of Rs 13.05 cr on DyStar legal costs. Auditor noted emphasis of matter on DyStar-Senda dispute. SPA with Zhejiang Longsheng pending as long-stop date extended to Dec 1, 2025 after missed deadlines. Kiri entitled to about USD 700 million from DyStar en bloc sale. Company also allotted 43.93 lakh shares on warrant conversion.

Likely market impact

Revenue growth is strong but losses persist and DyStar sale delay adds uncertainty. Watch for Dec 1 deadline outcome and share dilution from warrant conversion.